‘Capture the high-priced private market’… Premium vaccine competition outside of NIP

‘Capture the high-priced private market’… Premium vaccine competition outside of NIP

RSV, HPV, shingles high value-added vaccine market… Intense competition led by global big pharma (Graphics = Reporter Son Mi-kyung sssmk@) Attention is being paid to whether premium vaccines can be a way for pharmaceutical and bio companies to increase sales. Although there is no government support, companies are competing to secure market share in the … Read more

Very harmful, contract with Sanofi: owner of Birmex

Very harmful, contract with Sanofi: owner of Birmex

The public-private partnership contract between the Biological and Reactive laboratories of Mexico (Birmex) and Sanofi It was very harmful to the Mexican State. It is valid for 15 years and will end in 2032. During this period, the company has the exclusivity to sell 15 million influenza vaccines and more than one million hexavalent vaccines … Read more

an experimental drug does not prove itself

an experimental drug does not prove itself

Sanofi announced on September 2, 2024 that its experimental multiple sclerosis drug tolebrutinib failed to meet the primary endpoint of two late-stage clinical trials. September 2, 2024 • By Handicap.fr with AFP Disappointment. On September 2, 2024, the French pharmaceutical group Sanofi indicated in a press release that the treatment studied did not demonstrate a … Read more

WHO: Corona vaccination has saved the lives of 1.6 million people in Europe

WHO: Corona vaccination has saved the lives of 1.6 million people in Europe

Did the vaccination against Corona save lives or was it disproportionately risky given the side effects that occurred in some cases? Researchers from the UN World Health Organization (WHO) have now presented an estimate based on data. According to this, around 1.6 million lives were saved in Europe by the vaccinations between December 2020 and … Read more

The White House Announces Additional 230,000 Doses of RSV Vaccine for Infants – Sanofi and AstraZeneca Delivery Plans 2024

The White House Announces Additional 230,000 Doses of RSV Vaccine for Infants – Sanofi and AstraZeneca Delivery Plans 2024

International news 4:33 p.m. 2023-12-15 The White House said Thursday (Dec. 14) that Sanofi and AstraZeneca (AstraZeneca) plans to deliver an additional 230,000 doses of respiratory syncytial virus (RSV) vaccine to infants in January. 2024 after US officials held discussions with both companies about winter vaccine delivery. Sanofi said in a statement: The company will … Read more

Read the news in Chinese and English》A new RSV shot for infants is in short supply A new RSV shot for infants is in short supply – International

Read the news in Chinese and English》A new RSV shot for infants is in short supply A new RSV shot for infants is in short supply – International

2023/11/20 05:30 The new vaccine “Beyfortus” against infant respiratory syncytial virus (RSV) is in short supply. (Associated Press) ◎Chen Chengliang A new shot for infants against RSV is in short supply, and U.S. health officials told doctors they should prioritize giving the drug to babies at the highest risk of severe disease. A new vaccine … Read more

The Best Plan for Winter: Vaccination Against Flu, Covid-19, and Pneumonia

The Best Plan for Winter: Vaccination Against Flu, Covid-19, and Pneumonia

‘The best plan for this winter’ is the motto with which the Spanish Association of Vaccinology wants to raise awareness among the population to get vaccinated now to be protected during the winter. With this campaign, the AEV invites people aged 60 or over and the vulnerable population to get vaccinated against flu, Covid-19 and … Read more

Euroapi Stock Plummets 60% Amid Downward Revision of Financial Forecasts

Euroapi Stock Plummets 60% Amid Downward Revision of Financial Forecasts

The French manufacturer of active pharmaceutical ingredients Euroapi fell 60% on the stock market on Tuesday morning, investors taking note of a new downward revision of financial forecasts for 2023 and beyond. The stock took a long time to be listed after the opening, before plunging more than 60% in early trading. Around 10:35 a.m., … Read more

“New Stiko Recommendations for COVID Booster Vaccinations and Endemic State”

“New Stiko Recommendations for COVID Booster Vaccinations and Endemic State”

Only older people over the age of 60 and people with risk factors for a severe course of the corona virus should continue to receive booster vaccinations, preferably in autumn, when they are also vaccinated against influenza or pneumococci. This also applies to employees of nursing homes and clinics. However, the Stiko has not yet … Read more

Sanofi, pharmaceutical firm, reduces the cost of insulin in the United States.

Sanofi, pharmaceutical firm, reduces the cost of insulin in the United States.

The pharmaceutical company Sanofi announced on March 16 that will reduce up to 78% the priceor its most prescribed insulin product in the United States, joining two other major producers of the drug that have announced similar measures in recent weeks. Sanofi will invest 19 million dollars in Mexico in research and therapies Read more … Read more